AI Advances in Healthcare: Specialty Pharmacy Investment & Neurological Care Developments – July 2026

Key points

• •Evernorth has committed $100 million as of July 2026 to build AI-enhanced specialty pharmacy services that aim to improve drug management and patient care personalization, marking a major investment in AI healthcare infrastructure.[MedCity News]
• •CorVista Health's introduction of new AMA Category III CPT® codes in 2024 for augmentative AI analysis of cardiopulmonary disease supports the clinical integration and reimbursement of diagnostic AI technologies in the healthcare system.[Yahoo Finance]
• •University of Bath launched the £7.6 million CEREBRIS project in July 2026 to develop next-generation AI tools targeting neurological disorder diagnosis and treatment, signifying a substantial funding initiative for AI in neurology.[University of Bath]
• •AI applications showed promising clinical impact with researchers in June 2026 identifying a hidden ECG signal via AI that can predict sudden cardiac death risk, enhancing early diagnosis and preventive cardiology care.[Yahoo Health]
• •Healthcare institutions are expanding AI-assisted patient care, illustrated by Saint Peter’s Healthcare System’s use of hellocare.ai to boost patient safety and virtual care in hospital settings as of July 2026.[Fierce Healthcare]
• •AI-driven health navigation platforms are emerging, exemplified by Sharecare’s July 2026 partnership with AWS to launch an AI-powered system personalizing health guidance, reflecting integration of AI in consumer health management.[Digital Health News]
• •Promising AI innovations in medical education and surgery were demonstrated when a surgical AI by a King's College London medical student placed third globally in Harvard’s health venture programme in July 2026.[King's College London]
• •International advancements in AI healthcare include South Korea’s Kyung Hee University Hospital selection in July 2026 to develop 'Dr. Answer 3.0,' an AI system focusing on diabetes management and diagnosis.[koreabiomed.com]
• •Anthropic’s entry into healthcare AI in July 2026 with a drug discovery program exemplifies the expanding role of AI companies in accelerating medical research and pharmaceutical innovation.[India Today]
• •Regional developments such as the Space Coast experts’ discussion in July 2026 highlight AI’s transformative role in medical lab result interpretation, improving diagnostic accuracy and clinical decision-making.[FOX 35 Orlando]

Relevant articles